Avanos Medical, Inc.
US ˙ NYSE ˙ US05350V1061

SecurityAVNS / Avanos Medical, Inc.
InstitutionD. E. Shaw & Co., Inc.
ManagerDE Shaw
Latest Disclosed Ownership671,413 shares
Latest Disclosed Value $ 9,406,496
D. E. Shaw & Co., Inc. ownership in AVNS / Avanos Medical, Inc.

On May 15, 2026 - D. E. Shaw & Co., Inc. filed a 13F-HR form disclosing ownership of 671,413 shares of Avanos Medical, Inc. (US:AVNS) valued at $9,406,496 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,210,456 shares of Avanos Medical, Inc.. This represents a change in shares of -44.53% during the quarter. The current value of the position is $16,771,897 USD.

D. E. Shaw & Co., Inc. has a history of taking positions in derivatives of the underlying security (AVNS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AVNS / Avanos Medical, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F AVANOS MED COM 05350V106 671,413 -539,043 -44.53 9,406 -30.80 0.0057
2026-02-17 2025-12-31 13F AVANOS MED COM 05350V106 1,210,456 -88,587 -6.82 13,593 -9.48 0.0075
2025-11-14 2025-09-30 13F AVANOS MED COM 05350V106 1,299,043 107,121 8.99 15,017 2.93 0.0085
2025-08-14 2025-06-30 13F AVANOS MED COM 05350V106 1,191,922 102,947 9.45 14,589 -6.51 0.0103
2025-05-15 2025-03-31 13F AVANOS MED COM 05350V106 1,088,975 594,348 120.16 15,605 98.18 0.0139
2025-02-14 2024-12-31 13F AVANOS MED COM 05350V106 494,627 148,902 43.07 7,874 -5.21 0.0058
2024-11-14 2024-09-30 13F AVANOS MED COM 05350V106 345,725 -140,822 -28.94 8,308 -14.29 0.0071
2024-08-14 2024-06-30 13F AVANOS MED COM 05350V106 486,547 74,767 18.16 9,692 18.22 0.0091
2024-05-15 2024-03-31 13F AVANOS MED COM 05350V106 411,780 77,663 23.24 8,199 9.39 0.0070
2024-02-14 2023-12-31 13F AVANOS MED COM 05350V106 334,117 -43,996 -11.64 7,494 -1.98 0.0065
2023-11-14 2023-09-30 13F AVANOS MED COM 05350V106 378,113 8,548 2.31 7,645 -19.07 0.0080
2023-08-14 2023-06-30 13F AVANOS MED COM 05350V106 369,565 -147,816 -28.57 9,446 -38.61 0.0096
2023-05-15 2023-03-31 13F AVANOS MED COM 05350V106 517,381 -98,641 -16.01 15,387 -7.70 0.0165
2023-02-14 2022-12-31 13F AVANOS MED COM 05350V106 616,022 -102,999 -14.32 16,670 6.44 0.0184
2022-11-14 2022-09-30 13F AVANOS MED COM 05350V106 719,021 -61,613 -7.89 15,660 -26.63 0.0187
2022-08-15 2022-06-30 13F AVANOS MED COM 05350V106 780,634 -116,815 -13.02 21,343 -29.01 0.0250
2022-05-16 2022-03-31 13F AVANOS MED COM 05350V106 897,449 124,254 16.07 30,065 12.15 0.0281
2022-02-14 2021-12-31 13F AVANOS MED COM 05350V106 773,195 70,960 10.10 26,807 22.35 0.0222
2021-11-15 2021-09-30 13F AVANOS MED COM 05350V106 702,235 187,548 36.44 21,910 17.04 0.0198
2021-08-16 2021-06-30 13F AVANOS MED COM 05350V106 514,687 320,127 164.54 18,720 119.98 0.0162
2021-05-17 2021-03-31 13F AVANOS MED COM 05350V106 194,560 25,620 15.17 8,510 9.79 0.0082
2021-02-16 2020-12-31 13F AVANOS MED COM 05350V106 168,940 -74,638 -30.64 7,751 -4.21 0.0069
2020-11-16 2020-09-30 13F AVANOS MED COM 05350V106 243,578 -59,790 -19.71 8,092 -9.24 0.0083
2020-08-14 2020-06-30 13F AVANOS MED COM 05350V106 303,368 68,287 29.05 8,916 40.83 0.0106
2020-05-15 2020-03-31 13F AVANOS MED COM 05350V106 235,081 144,048 158.24 6,331 106.36 0.0099
2020-02-14 2019-12-31 13F AVANOS MED COM 05350V106 91,033 -168,543 -64.93 3,068 -68.45 0.0035
2019-11-14 2019-09-30 13F AVANOS MED COM 05350V106 259,576 18,238 7.56 9,724 -7.61 0.0120
2019-08-14 2019-06-30 13F AVANOS MED COM 05350V106 241,338 -146,265 -37.74 10,525 -36.38 0.0131
2019-05-15 2019-03-31 13F AVANOS MED COM 05350V106 387,603 41,508 11.99 16,543 6.72 0.0214
2019-02-14 2018-12-31 13F AVANOS MED COM 05350V106 346,095 279,054 416.24 15,502 237.59 0.0214
2018-11-14 2018-09-30 13F AVANOS MED COM 05350V106 67,041 13,510 25.24 4,592 49.82 0.0055
2018-08-14 2018-06-30 13F HALYARD HEALTH COM 40650V100 53,531 44,881 518.86 3,065 668.17 0.0040
2018-05-15 2018-03-31 13F HALYARD HEALTH COM 40650V100 8,650 -14,638 -62.86 399 -62.88 0.0005
2018-02-14 2017-12-31 13F HALYARD HEALTH COM 40650V100 23,288 6,550 39.13 1,075 42.57 0.0015
2017-11-14 2017-09-30 13F HALYARD HEALTH COM 40650V100 16,738 -52,906 -75.97 754 -72.44 0.0012
2017-08-14 2017-06-30 13F HALYARD HEALTH COM 40650V100 69,644 -42,922 -38.13 2,736 -36.19 0.0045
2017-05-15 2017-03-31 13F HALYARD HEALTH COM 40650V100 112,566 24,457 27.76 4,288 31.61 0.0075
2017-02-14 2016-12-31 13F HALYARD HEALTH COM 40650V100 88,109 -131,314 -59.85 3,258 -57.16 0.0055
2016-11-14 2016-09-30 13F HALYARD HEALTH COM 40650V100 219,423 123,441 128.61 7,605 143.67 0.0134
2016-08-15 2016-06-30 13F HALYARD HEALTH COM 40650V100 95,982 15,958 19.94 3,121 35.75 0.0058
2016-05-16 2016-03-31 13F HALYARD HEALTH COM 40650V100 80,024 -130,477 -61.98 2,299 -67.31 0.0041
2016-02-16 2015-12-31 13F HALYARD HEALTH COM 40650V100 210,501 -143,255 -40.50 7,033 -30.10 0.0105
2015-11-16 2015-09-30 13F HALYARD HEALTH COM 40650V100 353,756 -5,920 -1.65 10,061 -30.93 0.0148
2015-08-14 2015-06-30 13F HALYARD HEALTH COM 40650V100 359,676 237,644 194.74 14,567 142.62 0.0217
2015-05-15 2015-03-31 13F HALYARD HEALTH COM 40650V100 122,032 34,900 40.05 6,004 51.54 0.0092
2015-02-17 2014-12-31 13F HALYARD HEALTH COM 40650V100 87,132 87,132 3,962 0.0051
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-05-16 2016-03-31 13F HALYARD HEALTH COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-16 2015-12-31 13F HALYARD HEALTH COM Call 6,288 -17.48 210 -3.23 n/a n/a n/a
2015-11-16 2015-09-30 13F HALYARD HEALTH COM Call 7,620 0.00 217 -29.77 n/a n/a n/a
2015-08-14 2015-06-30 13F HALYARD HEALTH COM Call 7,620 0.00 309 -17.60 n/a n/a n/a
2015-05-15 2015-03-31 13F HALYARD HEALTH COM Call 7,620 0.00 375 8.38 n/a n/a n/a
2015-02-17 2014-12-31 13F HALYARD HEALTH COM Call 7,620 346 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-11-14 2016-09-30 13F HALYARD HEALTH COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-08-15 2016-06-30 13F HALYARD HEALTH COM Put 50,000 -50.00 1,626 -43.40 n/a n/a n/a
2016-05-16 2016-03-31 13F HALYARD HEALTH COM Put 100,000 752.95 2,873 632.91 n/a n/a n/a
2016-02-16 2015-12-31 13F HALYARD HEALTH COM Put 11,724 0.00 392 17.72 n/a n/a n/a
2015-11-16 2015-09-30 13F HALYARD HEALTH COM Put 11,724 0.00 333 -29.89 n/a n/a n/a
2015-08-14 2015-06-30 13F HALYARD HEALTH COM Put 11,724 0.00 475 -17.68 n/a n/a n/a
2015-05-15 2015-03-31 13F HALYARD HEALTH COM Put 11,724 -70.26 577 -67.80 n/a n/a n/a
2015-02-17 2014-12-31 13F HALYARD HEALTH COM Put 39,420 1,792 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.